Home Contact Shopping Video

Correction to: CB1 Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling, by Gamage TF, Anderson JC, and Abood ME. Cannabis Cannabinoid Res. 2016;1(1):272–280. DOI: 10.1089/can.2016.0028

November 19th, 2019 cannacan Posted in Cannabinoid Research Comments Off on Correction to: CB1 Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling, by Gamage TF, Anderson JC, and Abood ME. Cannabis Cannabinoid Res. 2016;1(1):272–280. DOI: 10.1089/can.2016.0028

Correction to: CB1 Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling, by Gamage TF, Anderson JC, and Abood ME. Cannabis Cannabinoid Res. 2016;1(1):272–280. DOI: 10.1089/can.2016.0028

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice

November 14th, 2019 cannacan Posted in Cannabinoid Research Comments Off on Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice

Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

The Impact of Perioperative Cannabis Use: A Narrative Scoping Review

November 14th, 2019 cannacan Posted in Cannabinoid Research Comments Off on The Impact of Perioperative Cannabis Use: A Narrative Scoping Review

The Impact of Perioperative Cannabis Use: A Narrative Scoping Review

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

Knowledge, Practices, and Attitudes of Washington State Health Care Professionals Regarding Medical Cannabis

November 11th, 2019 cannacan Posted in Cannabinoid Research Comments Off on Knowledge, Practices, and Attitudes of Washington State Health Care Professionals Regarding Medical Cannabis

Knowledge, Practices, and Attitudes of Washington State Health Care Professionals Regarding Medical Cannabis

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats

November 2nd, 2019 cannacan Posted in Cannabinoid Research Comments Off on Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats

Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey

October 29th, 2019 cannacan Posted in Cannabinoid Research Comments Off on Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey

Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

Survey of Pharmacists’ Knowledge of Connecticut’s Medical Cannabis Program

October 10th, 2019 cannacan Posted in Cannabinoid Research Comments Off on Survey of Pharmacists’ Knowledge of Connecticut’s Medical Cannabis Program

Survey of Pharmacists' Knowledge of Connecticut's Medical Cannabis Program

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

Impact of At Least 2 Years of Synthetic Cannabinoid Use on Cognitive and Psychomotor Functions Among Treatment-Seeking Male Outpatients

October 10th, 2019 cannacan Posted in Cannabinoid Research Comments Off on Impact of At Least 2 Years of Synthetic Cannabinoid Use on Cognitive and Psychomotor Functions Among Treatment-Seeking Male Outpatients

Impact of At Least 2 Years of Synthetic Cannabinoid Use on Cognitive and Psychomotor Functions Among Treatment-Seeking Male Outpatients

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

Oral Cannabidiol Does Not Convert to Δ8-THC or Δ9-THC in Humans: A Pharmacokinetic Study in Healthy Subjects

October 5th, 2019 cannacan Posted in Cannabinoid Research Comments Off on Oral Cannabidiol Does Not Convert to Δ8-THC or Δ9-THC in Humans: A Pharmacokinetic Study in Healthy Subjects

Oral Cannabidiol Does Not Convert to Δ8-THC or Δ9-THC in Humans: A Pharmacokinetic Study in Healthy Subjects

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button

2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity

October 1st, 2019 cannacan Posted in Cannabinoid Research Comments Off on 2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity

2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

AddThis Social Bookmark Button